Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -108,296 | -59,374 | -157,128 | -131,643 | -81,035 |
| Depreciation Amortization | 1,535 | 723 | 2,388 | 1,752 | 1,180 |
| Income taxes - deferred | -5,172 | -69 | -1,621 | -7,550 | -7,991 |
| Accounts receivable | 49,089 | 48,901 | -42,753 | 6,936 | 9,355 |
| Accounts payable and accrued liabilities | -687 | -3,663 | 310 | -411 | 970 |
| Other Working Capital | 37,932 | 32,911 | -48,725 | 10,272 | 14,923 |
| Other Operating Activity | -24,781 | -34,821 | 109,218 | 35,947 | -24,294 |
| Operating Cash Flow | $-50,380 | $-15,392 | $-138,311 | $-84,697 | $-86,892 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,228 | -1,016 | -687 | -473 | -279 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -1,708 | -1,648 |
| Other Investing Activity | 0 | 0 | 0 | -1,918 | -1,858 |
| Investing Cash Flow | $-2,228 | $-1,016 | $-687 | $-2,391 | $-2,137 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 115,597 | 114,490 | N/A |
| Debt Repayment | N/A | N/A | -118,304 | -118,070 | N/A |
| Common Stock Issued | N/A | 425 | 6,130 | 6,192 | N/A |
| Other Financing Activity | 73,527 | 0 | -4,320 | -757 | -510 |
| Financing Cash Flow | $73,527 | $425 | $-897 | $1,855 | $-510 |
| Exchange Rate Effect | 150 | 89 | -208 | -451 | -227 |
| Beginning Cash Position | 326,441 | 326,441 | 466,544 | 466,544 | 466,544 |
| End Cash Position | 347,510 | 310,547 | 326,441 | 380,860 | 376,778 |
| Net Cash Flow | $21,069 | $-15,894 | $-140,103 | $-85,684 | $-89,766 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,380 | -15,392 | -138,311 | -84,697 | -86,892 |
| Capital Expenditure | -2,228 | -1,016 | -687 | -473 | -279 |
| Free Cash Flow | -52,608 | -16,408 | -138,998 | -85,170 | -87,171 |